Asparaginase Escherichia coli-derived - EUSA Pharma
Alternative Names: E. coli L-asparaginase; Kidrolase; L-asparaginaseLatest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator EUSA Pharma
- Class Amidohydrolases; Antineoplastics
- Mechanism of Action Asparagine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lymphomatous meningitis; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 12 Jun 2012 EUSA Pharma has been acquired by Jazz Pharmaceuticals plc
- 01 Dec 2010 Launched for Acute lymphoblastic leukaemia in Algeria before 2011 (IM)
- 01 Dec 2010 Launched for Acute lymphoblastic leukaemia in Algeria before 2011 (IV)